GlassScriptPhysician profile
Susan Hsu
NPI 1740243773
$3,173.27
in general payments reported to CMS, 2019-2025
27 companies · $532 in 2025
The $532 reported for 2025 was more than what 82% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $404 · 2020: $467 · 2021: $431 · 2022: $506 · 2023: $434 · 2024: $399 · 2025: $532.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,364.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $687.95 | 2021-2025 | |
| Abbvie INC. | $343.86 | 2019-2022 | |
| Myovant Sciences INC. | $339.38 | 2021-2022 | |
| Therapeuticsmd, INC. | $287.17 | 2019-2021 | |
| Astellas Pharma US INC | $260.04 | 2024-2025 | Veozah |
| Sumitomo Pharma America, INC. | $220.19 | 2023-2025 | Myfembree |
| Merck Sharp & Dohme LLC | $153.21 | 2019-2025 | Gardasil 9 |
| Alnylam Pharmaceuticals INC. | $124.99 | 2024 | Amvuttra |
| Intuitive Surgical, INC. | $113.67 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $108.58 | 2019-2023 | |
| Agile Therapeutics, INC. | $87.98 | 2021-2023 | Twirla |
| Hologic Sales and Service, LLC | $74.19 | 2019-2023 | Acessa Provu System |
| Organon LLC | $46.25 | 2021-2024 | |
| Allergan, INC. | $36.07 | 2019 | |
| Coopersurgical, INC. | $32.35 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $32.31 | 2023 | |
| Zyla Life Sciences, INC. | $30.40 | 2020 | |
| Sage Therapeutics, LLC | $29.74 | 2024 | |
| Ethicon US, LLC | $22.16 | 2020 | |
| Davol INC. | $21.69 | 2022 | |
| Dysis Medical, INC. | $21.36 | 2022 | |
| Becton, Dickinson and Company | $19.04 | 2022 | |
| Janssen Pharmaceuticals, INC | $18.29 | 2021 | |
| Medicem INC. | $17.82 | 2020 | |
| Axonics, INC. | $15.42 | 2020 | |
| Aspira Women'S Health INC | $15.19 | 2023 | Ova1 |
| Daiichi Sankyo INC. | $13.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Hsu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.